Topic: T4P News

December 13, 2021

Mont-Saint-Guibert, Belgium (December 14, 2021): Tools4Patient‘s Placebell©™ was named one of the most innovative products of 2021 by PM360, a leading trade magazine for marketing decision-makers in the pharmaceutical, biotech, medical device and diagnostics industries. Placebell is an innovative predictive method that addresses this complex challenge of the placebo response in clinical trials. Placebell combines machine learning-based algorithms with individual patient

December 15, 2020

With 2020 coming to a close, it is an opportune time to pause and reflect on the progress we have made as an industry, as a company and as individuals.  We congratulate our partners and friends for their ingenuity and perseverance in rising to the challenges of the year.  We look forward to continued progress in 2021 and share our warmest wishes for health, happiness and peace.

September 24, 2020

The Tools4Patient team has moved our offices to a new building located in the same scientific campus in Louvain-La-Neuve, Belgium in early September, 2020. The rapid expansion of collaborations with innovative biopharma companies has led to 30% growth of our team – particularly in scientific and operational support areas – over the last year.

January 29, 2020

As 2019 came to a close and we begin a new decade, it’s an excellent opportunity to evaluate and learn from the past year and set a course for the future. Tools4Patient (T4P) had a momentous year as we increased on our focus on the commercialization of Placebell©™ – T4P’s innovative approach to reduce the impact of the

September 16, 2019

Tools4Patient’s Placebell©™ technology has been selected as a finalist in the 2019 Clinical Trials Innovation Challenge sponsored by IQVIA, Lundbeck, and LEO Innovation Lab.

September 3, 2019

Tools4Patient is committed to our mission of developing predictive tools to optimize the evaluation of clinical-stage drugs. Along with our recent launch of Placebell©™ – a predictive algorithm focused on the placebo response – and our recent fundraising to support commercialization of Placebell©™ and further R&D, T4P is entering a new phase as a company.